NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

全球人體類器官市場:產品的各實用性,各用途,各終端用戶,各地區預測(2020∼2027年)

Global Human Organoids Market by Product Usability, Application, End-user and Regional Forecasts 2020-2027

出版商 Bizwit Research & Consulting LLP 商品編碼 980312
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
全球人體類器官市場:產品的各實用性,各用途,各終端用戶,各地區預測(2020∼2027年) Global Human Organoids Market by Product Usability, Application, End-user and Regional Forecasts 2020-2027
出版日期: 2020年12月20日內容資訊: 英文
簡介

全球人體類器官的市場規模2019年約7億2,340萬美金。該市場預計從2020年到2027年的預測期間以超越17.5%的健全成長率成長。

類器官,是從幹細胞採取的顯微鏡下的自組織的組織培養。收集這樣的培養物,複製內臟器官大部分複雜性,僅生成已確立類型的細胞等,表達其優選方面。這個市場,由於移植的需求高漲預計大幅度成長。

本報告提供全球人體類器官市場相關調查,市場概要,以及產品的各實用性,各用途,各終端用戶,各地區的趨勢,及加入此市場的主要企業簡介等資訊。

目錄

第1章 摘要整理

第2章 全球人體類器官市場定義和範圍

第3章 全球人體類器官市場動態

  • 人體類器官市場影響分析(2018-2027)

第4章 全球人體類器官市場處理分析

  • 波特五力模式
    • 供給企業談判力
    • 買方議價能力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係
    • 波特5力模式的未來方法(2017∼2027年)
  • PEST分析
    • 政治
    • 經濟
    • 社會
    • 技術性
  • 投資採用模式
  • 分析師的推薦事項與結論

第5章 全球人體類器官市場:各產品

  • 市場概述
  • 全球人體類器官市場,各產品-潛力分析
  • 全球人體類器官市場預算與預測,各產品:2017∼2027年(百萬美元)
  • 人體類器官市場,子區隔分析
    • 胰臟
    • 腎臟
    • 消化管
    • 肝臟模式

第6章 全球人體類器官市場:各用途

  • 市場概述
  • 全球人體類器官市場,各用途-潛力分析
  • 全球人體類器官市場預算與預測,各用途:2017∼2027年(百萬美元)
  • 人體類器官市場,子區隔分析
    • 毒性
    • 病理學
    • 個人化醫療
    • 再生醫療

第7章 全球人體類器官市場:各最終用途

  • 市場概述
  • 全球人體類器官市場,各最終用途-潛力分析
  • 全球人體類器官市場預算與預測,各最終用途:2017∼2027年(百萬美元)
  • 人體類器官市場,子區隔分析
    • 客製化品
    • 現成品

第8章 競爭資訊

  • 最高市場策略
  • 企業簡介
    • BioIVT (美國)
    • Thermo Fisher Scientific (美國)
    • ZenBio (美國)
    • Corning (美國)
    • Organovo (美國)
    • Cyprid (法國)
    • Biopredic International (法國)
    • CELLINK (瑞典)
    • Emulate (美國)
  • H?rel Corporation(美國)

第9章 調查流程

目錄

Title:
Global Human Organoids Market by Product (Pancreas, Kidney, Lung, GIT, Liver Models) Usability (Customized, Ready-To-Use), Application (Toxicity, Pathology, Personalized & Regenerative Medicine), End-user (Pharma-Biotech, CROs, Academia) and Regional Forecasts 2020-2027 .

Global Human Organoids Market is valued approximately at USD 723.40 million in 2019 and is anticipated to grow with a healthy growth rate of more than 17.5 % over the forecast period 2020-2027. Organoids are microscopic, self-organized tissue cultures taken from stem cells. Such cultures can be collected to duplicate much of the intricacy of an organ, or to express preferred aspects of it like producing only convinced types of cells. This market is expected to grow significantly due to the rising demand in transplants. Earlier its was challenging to provide a transplant as the organs such as kidney, liver, and heart have very few minutes to function properly due to lack of oxygen after a person is declared brain dead. Now with much efficient supply chain and transportation it has become much more convenient. Constant evolution in the genetic codes has made it troublesome to use animals for testing drugs and due to the stringent rules enforced by the government to contain animal cruelty has boosted the human organoid market. In 2019, Organovo partnered with MCRI and Leiden University Medical Center to develop stem cell-based bio printed tissue treatment for kidney diseases. However, the market lacks the skilled researchers and scientists needed to bridge the gap between mankind and technology owing to the complications involved in this procedure. Incorporation of cultured cells in a new biological environment can be affected due to various technical challenges.

The regional analysis of global Human Organoids Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising demand for new and improved drugs. Whereas Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the need to develop cost effective drugs would create lucrative growth prospects for the Human Organoids Market across Asia-Pacific region.

Major market player included in this report are:

BioIVT (US)

Thermo Fisher Scientific (US)

ZenBio (US)

Corning (US)

Organovo (US)

Cyprid (France)

Biopredic International (France)

CELLINK (Sweden)

Emulate (US)

Hµrel Corporation (US)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Products:

Pancreas

Kidney

Lung

GIT

Liver Models

By Usability:

Customized

Ready-To-Use

By Application:

Toxicity

Pathology

Personalized

Regenerative Medicine

By End-User:

Pharma-Biotech

CROs

Academia

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2017, 2018

Base year - 2019

Forecast period - 2020 to 2027

Target Audience of the Global Human Organoids Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Million)
    • 1.2.1. Human Organoids Market, by Region, 2018-2027 (USD Million)
    • 1.2.2. Human Organoids Market, by Product, 2018-2027 (USD Million)
    • 1.2.3. Human Organoids Market, by Application, 2018-2027 (USD Million)
    • 1.2.4. Human Organoids Market, by End-User, 2018-2027 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Human Organoids Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Processing Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Human Organoids Market Dynamics

  • 3.1. Human Organoids Market Impact Analysis (2018-2027)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Human Organoids Market Processing Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2017-2027)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Human Organoids Market, by Product

  • 5.1. Market Snapshot
  • 5.2. Global Human Organoids Market by Type, Product - Potential Analysis
  • 5.3. Global Human Organoids Market Estimates & Forecasts by Product 2017-2027 (USD Million)
  • 5.4. Human Organoids Market, Sub Segment Analysis
    • 5.4.1. Pancreas
    • 5.4.2. Kidney
    • 5.4.3. Lung
    • 5.4.4. GIT
    • 5.4.5. Liver Models

Chapter 6. Global Human Organoids Market, by Application

  • 6.1. Market Snapshot
  • 6.2. Global Human Organoids Market by Processing, Application - Potential Analysis
  • 6.3. Global Human Organoids Market Estimates & Forecasts by Application 2017-2027 (USD Million)
  • 6.4. Human Organoids Market, Sub Segment Analysis
    • 6.4.1. Toxicity
    • 6.4.2. Pathology
    • 6.4.3. Personalized
    • 6.4.4. Regenerative Medicine

Chapter 7. Global Human Organoids Market, by Use-End

  • 7.1. Market Snapshot
  • 7.2. Global Human Organoids Market by Processing, User-End - Potential Analysis
  • 7.3. Global Human Organoids Market Estimates & Forecasts by User-End 2017-2027 (USD Million)
  • 7.4. Human Organoids Market, Sub Segment Analysis
    • 7.4.1. Customized
    • 7.4.2. Ready-To-Use

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. BioIVT (US)
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Product Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. Thermo Fisher Scientific (US)
    • 8.2.3. ZenBio (US)
    • 8.2.4. Corning (US)
    • 8.2.5. Organovo (US)
    • 8.2.6. Cyprid (France)
    • 8.2.7. Biopredic International (France)
    • 8.2.8. CELLINK (Sweden)
    • 8.2.9. Emulate (US)
  • 9.2.10Hµrel Corporation (US)

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Human Organoids market, report scope
  • TABLE 2. Global Human Organoids market estimates & forecasts by Region 2017-2027 (USD Million)
  • TABLE 3. Global Human Organoids market estimates & forecasts by Products 2017-2027 (USD Million)
  • TABLE 4. Global Human Organoids market estimates & forecasts by Application 2017-2027 (USD Million)
  • TABLE 5. Global Human Organoids market estimates & forecasts by End-User 2017-2027 (USD Million)
  • TABLE 6. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 7. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 8. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 9. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 10. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 11. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 12. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 13. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 14. Global Human Organoids market by segment, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 15. Global Human Organoids market by region, estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 16. U.S. Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 17. U.S. Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 18. U.S. Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 19. Canada Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 20. Canada Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 21. Canada Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 22. UK Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 23. UK Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 24. UK Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 25. Germany Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 26. Germany Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 27. Germany Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 28. RoE Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 29. RoE Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 30. RoE Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 31. China Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 32. China Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 33. China Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 34. India Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 35. India Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 36. India Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 37. Japan Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 38. Japan Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 39. Japan Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 40. RoAPAC Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 41. RoAPAC Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 42. RoAPAC Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 43. Brazil Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 44. Brazil Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 45. Brazil Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 46. Mexico Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 47. Mexico Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 48. Mexico Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 49. RoLA Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 50. RoLA Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 51. RoLA Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 52. Row Human Organoids market estimates & forecasts, 2017-2027 (USD Million)
  • TABLE 53. Row Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 54. Row Human Organoids market estimates & forecasts by segment 2017-2027 (USD Million)
  • TABLE 55. List of secondary sources, used in the study of global Human Organoids market
  • TABLE 56. List of primary sources, used in the study of global Human Organoids market
  • TABLE 57. Years considered for the study
  • TABLE 58. Exchange rates considered

LIST OF FIGURES

List of figures

  • FIG 1. Global Human Organoids market, research methodology
  • FIG 2. Global Human Organoids market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods
  • FIG 4. Global Human Organoids market, key trends 2019
  • FIG 5. Global Human Organoids market, growth prospects 2020-2027
  • FIG 6. Global Human Organoids market, porters 5 force model
  • FIG 7. Global Human Organoids market, pest analysis
  • FIG 8. Global Human Organoids market, value chain analysis
  • FIG 9. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
  • FIG 10. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
  • FIG 11. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
  • FIG 12. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
  • FIG 13. Global Human Organoids market by segment, 2017 & 2027 (USD Million)
  • FIG 14. Global Human Organoids market, regional snapshot 2017 & 2027
  • FIG 15. North America Human Organoids market 2017 & 2027 (USD Million)
  • FIG 16. Europe Human Organoids market 2017 & 2027 (USD Million)
  • FIG 17. Asia pacific Human Organoids market 2017 & 2027 (USD Million)
  • FIG 18. Latin America Human Organoids market 2017 & 2027 (USD Million)
  • FIG 19. Global Human Organoids market, company market share analysis (2019)